covance.net valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Contract Research Organization (CRO) and Clinical Trials | Labcorp Drug |
| Description | Propel your development program forward with the power and speed of a global laboratory Labcorp Drug Development (formerly Covance) is a global contract research organization (CRO) that provides drug development services with the goal of advancing health. We have supported the development of the top 50 pharmaceutical drugs on the |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 162.134.132.9 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
covance.net Valuation
|
US$1,737
Last updated: 2023-05-09 16:06:45
covance.net has Semrush global rank of 0. covance.net has an estimated worth of US$ 1,737, based on its estimated Ads revenue. covance.net receives approximately 200 unique visitors each day. Its web server is located in United States, with IP address 162.134.132.9. According to SiteAdvisor, covance.net is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,737 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$48 |
| Yearly Ads Revenue | US$577 |
| Daily Unique Visitors | 13 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| covance.net. | A | 300 | IP: 162.134.132.9 |
| covance.net. | NS | 86400 | NS Record: dns3.labcorp.com. |
| covance.net. | NS | 86400 | NS Record: dns4.labcorp.com. |
| covance.net. | MX | 3600 | MX Record: 10 natestsmtp02.covance.net. |
| covance.net. | MX | 3600 | MX Record: 10 natestsmtp01.covance.net. |
| covance.net. | TXT | 300 | TXT Record: v=spf1 ip4:208.66.166.213 ip4:208.66.166.214 ip4:208.66.166.166 -all |
| covance.net. | TXT | 300 | TXT Record: MS=ms85396124 |
| covance.net. | TXT | 300 | TXT Record: pt8i6JPJh9DhNwYpKayEkgR8Bvy9Kb+PicxipFEXmCJOCmx4ju1UE003Be8kaZRvYSSTfxWtXr7rRJwOX/DAhQ== |
HtmlToTextCheckTime:2023-05-09 16:06:45
| Kit Orders Labcorp.com About Us Careers Contact Us Choose Language Development Solutions Development Solutions Back Drug Development Drug Development Back By Programs By Therapeutic By Therapeutic Back Pediatrics Cardiovascular Dermatology Diabetes and Endocrinology Inflammation NASH Neuroscience & CNS Rare & Orphan Ophthalmology Infectious Disease & Vaccines Nephrology Lung & Respiratory By Region By Region Back Asia Pacific Europe Americas By Molecule or Product By Molecule or Product Back Biologic Drug Development & Testing Small Molecule Biosimilars Development Solutions Oncology Oncology Back Preclinical Preclinical Back ACT & CAR T In vitro Tumor models Model & tech spotlights Posters Fast Track Discovery Immunotherapy Immunotherapy Back Clinical Preclinical ACT & CAR T Education Education Back Top 5 Models for Immuno-oncology Studies Top 5 Design Considerations for Preclinical Immuno-oncology Events Contact Clinical trials Clinical trials Back Consulting team Patient |
HTTP Headers
HTTP/1.0 302 Moved Temporarily
Location: https://www.covance.com
Server: BigIP
Connection: Keep-Alive
Content-Length: 0
HTTP/2 301
date: Mon, 01 Nov 2021 03:57:58 GMT
cache-control: max-age=3600
expires: Mon, 01 Nov 2021 04:57:58 GMT
location: https://drugdevelopment.labcorp.com/
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare
cf-ray: 6a7233b93c022c11-ORD
HTTP/2 200
date: Mon, 01 Nov 2021 03:57:58 GMT
content-type: text/html;charset=utf-8
set-cookie: AWSALB=b7N2/WSzfGMEISujTjG6B29XqZuhyfJRRutlJe4NMwiTK9N4O3dowe7cyd4rutBGoJ+OWf30I44h1NR2aVSjMfMqrqnrn7BlySd7ayo5DfwIrQS7MDd82i1bDV5y; Expires=Mon, 08 Nov 2021 03:57:58 GMT; Path=/
set-cookie: AWSALBCORS=b7N2/WSzfGMEISujTjG6B29XqZuhyfJRRutlJe4NMwiTK9N4O3dowe7cyd4rutBGoJ+OWf30I44h1NR2aVSjMfMqrqnrn7BlySd7ayo5DfwIrQS7MDd82i1bDV5y; Expires=Mon, 08 Nov 2021 03:57:58 GMT; Path=/; SameSite=None; Secure
x-content-type-options: nosniff
last-modified: Fri, 29 Oct 2021 13:10:43 GMT
cache-control: max-age=120960
expires: Tue, 02 Nov 2021 13:33:58 GMT
vary: Accept-Encoding,User-Agent
dispatcher: ${DISP_NUM}
x-dispatcher: ${DISP_NUM}
x-vhost: covance
x-frame-options: SAMEORIGIN
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare
cf-ray: 6a7233ba48282ada-ORD
|
covance.net Whois Information
Domain Name: COVANCE.NET Registry Domain ID: 6941281_DOMAIN_NET-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-05-28T05:10:21Z Creation Date: 1999-06-01T13:57:34Z Registry Expiry Date: 2022-06-01T13:58:09Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS3.LABCORP.COM Name Server: DNS4.LABCORP.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T13:21:11Z <<< |